‘We die! You make money!’ was one of the slogans that HIV activists chanted at the New York Stock Exchange in 1997 in protest at pharmaceutical companies whose high drug prices had barred millions of ...

The PIL moved by NGO Network of People Living with HIV/AIDS, alleges shortage of antiretroviral drugs for treating HIV ...

Zimbabwe's remarkable progress in HIV treatment faces a new hurdle as cases of resistance to the life-saving drug, Dolutegravir (DTG), emerge. With over 1.2 million people currently on Antiretroviral ...

In March 2013, the government-run drug rehab Hanoi released Hung Quang Pham early. They didn’t want the bone-thin heroin user ...

Raltegravir tablets are indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency ...

The study evaluated the efficacy and safety of Dovato in 230 antiretroviral treatment-naïve individuals with advanced HIV.

The pilot open-label randomized clinical trial demonstrated that the use of the drug in addition to protease inhibitor ...

ViiV Healthcare Announces Data Demonstrating Dovato (DTG/3TC) Is Highly Effective in Treatment-Naïve People With Advanced HIV ...

A post-hoc analysis of the study showed DTG/3TC was non-inferior to 3-drug therapy regardless of the participant ... multicentre study assessing the efficacy and safety of DTG/3TC in 230 ...

High HIV viral load prior to antiretroviral therapy (ART ... to transitioning to CAB+RPV to optimize treatment outcomes and does not support therapeutic drug monitoring. Prior to LA ART initiation, ...

Revolutionary new HIV drugs are being made available in 120 low-income countries, but many important populations are being left out. Sophie Cousins reports.